02159.HK
Mediwelcome Healthcare Management & Technology Inc.
HKSE · Healthcare · Medical - Healthcare Information Services · CN
HKD 1.70
+0.00%Income statement
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | 876.6M | 468.0M | 321.6M | 331.3M | 323.4M |
| Cost of Revenue | 682.8M | 373.3M | 270.6M | 301.4M | 290.8M |
| Gross Profit | 193.8M | 94.7M | 51.0M | 29.9M | 32.6M |
| Operating Expenses | |||||
| R&D Expense | 63.9M | 27.9M | 18.7M | 32.7M | 50.6M |
| SG&A Expense | 122.2M | 63.7M | 60.6M | 73.3M | 75.6M |
| General & Admin Expense | 49.1M | 37.8M | 39.9M | 51.0M | 50.1M |
| Selling & Marketing Expense | 39.3M | 25.9M | 20.7M | 22.3M | 25.5M |
| Other Expenses | — | 1.3M | 7.9M | 5.8M | (2.6M) |
| Total Operating Expenses | 186.1M | 92.9M | 87.2M | 111.8M | 123.5M |
| Cost and Expenses | 869.0M | 466.2M | 357.8M | 413.2M | 414.4M |
| Operating Income (EBIT) | 7.7M | 1.8M | (36.2M) | (81.9M) | (97.0M) |
| Non-Operating | |||||
| Interest Income | 377.9K | 235.7K | 264.0K | 415.0K | 623.0K |
| Interest Expense | 2.6M | 1.4M | 1.1M | 1.3M | 1.2M |
| Net Interest Income | (2.5M) | (1.2M) | (823.0K) | (889.0K) | (623.0K) |
| Other Non-Op Income/Expense | (5.9M) | 5.2M | (9.0M) | (14.5M) | 6.0M |
| Non-Operating Income (excl Interest) | — | — | 18.1M | 13.2M | — |
| EBT (Pre-Tax Income) | 1.8M | 7.0M | (45.2M) | (96.4M) | (91.0M) |
| Income Tax Expense | 1.2M | — | 1.8M | (287.0K) | 2.7M |
| Bottom Line | |||||
| Net Income | 4.6M | 10.0M | (45.2M) | (94.1M) | (89.2M) |
| Earnings from Cont. Ops | 556.8K | 7.0M | (46.9M) | (96.1M) | (93.7M) |
| Earnings from Discont. Ops | — | — | — | — | — |
| Bottom Line Net Income | 4.6M | 10.0M | (45.2M) | (94.1M) | (89.2M) |
| Per Share | |||||
| Basic EPS | (HK$0.01) | HK$0.04 | (HK$0.24) | (HK$0.49) | (HK$0.48) |
| Diluted EPS | (HK$0.01) | HK$0.04 | (HK$0.24) | (HK$0.49) | (HK$0.48) |
| Revenue Per Share | HK$3.84 | HK$2.05 | HK$1.68 | HK$1.73 | HK$1.74 |
| Shares | |||||
| Basic Shares Outstanding | 228.0M | 228.0M | 191.4M | 191.4M | 185.8M |
| Diluted Shares Outstanding | 228.0M | 228.0M | 191.4M | 191.4M | 185.8M |
| Profitability Metrics | |||||
| EBITDA | 12.7M | 2.8M | (33.6M) | (74.5M) | (69.1M) |
| D&A | 5.0M | 990.0K | 2.6M | 20.5M | 20.7M |
| EBIT | 7.7M | 1.8M | (36.2M) | (95.1M) | (89.8M) |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Jun 1, 2026